Skip to main content
Premium Trial:

Request an Annual Quote

Case Closed: Sep 5, 2012

The lawsuit between the University of Pennsylvania and Craig Thompson, the CEO of Memorial Sloan-Kettering Cancer Center in New York has been settled, reports Fierce Biotech. As Pharmalot's Ed Silverman recounts, the Abramson Family Cancer Research Institute at UPenn sued Thompson, its former scientific director, for using intellectual property belonging to the school to found Agios Pharmaceuticals. Penn asked for $1 billion in damages, while Thompson denied the charges.

Penn and Agios have settled the suit, and have now announced a new licensing agreement, Fierce Biotech adds. "We are pleased to be moving forward in a collaborative manner around newly identified intellectual property," says Chi Van Dang from the Abramson Cancer Center at Penn in a statement. "We look forward to working with Agios on this project and potentially other unrelated projects in the future."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.